Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 10/20 | 0.69 |
| ▸ | CCKAR | P32238 | 4/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8538176 | 1.00 | CCKBR (0.69) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL9057111 | 0.87 | CCKBR (0.71) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8538152 | 0.87 | CCKBR (0.71) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8774361 | 0.87 | CCKBR (0.66) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8538366 | 0.87 | CCKBR (0.66) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8775202 | 0.87 | CCKBR (0.66) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8538299 | 0.87 | CCKBR (0.66) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8538375 | 0.86 | CCKBR (0.71) | CCKBRCCKAR | |
| SCHEMBL8534720 | 0.85 | CCKBR (0.82) | CCKBRCCKARCYP3A4MAPTTSHR | |
| SCHEMBL8774345 | 0.85 | CCKBR (0.82) | CCKBRCCKARCYP3A4MAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0804425-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996004254-A2 | BENZODIAZEPINE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-02-15 | — | — | WO | disclosed |